Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.58 | -23.05 |
PEG Ratio (TTM) | 0.21 | 15.47 |
P/S Ratio (TTM) | 31.98 | 49.46 |
P/B Ratio (TTM) | 0.44 | 18.87 |
P/FCF Ratio (TTM) | -0.71 | -3.27 |
Price to 5YR AVG Earnings Ratio | N/A | -3.55 |
Price to 5YR AVG FCF Ratio | N/A | -9.37 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -56.43% | -5.14% |
ROE (TTM) | -62.01% | 16.69% |
Net Profit Margin (TTM) | -5,456.43% | -1,583.93% |
ROIC 5YR AVG | N/A | 15.15% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -3.92% | -1,417.71% | N/A |
Revenue | -25.00% | N/A | N/A |
Net Income | -10.94% | -1,435.70% | N/A |
Cash Flow | -10.79% | -463.87% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.14 | 6.13 |
Quick Ratio (TTM) | 5.14 | 5.85 |
D/E Ratio (TTM) | 0.25 | -15.81 |
Interest Coverage (TTM) | -97.29 | -1.57 |
Piotroski F-Score | 2 | 5 |
Altman Z-Score | N/A | 14.12 |
LTL to 5YR AVG FCF | N/A | 0.17 |
Shares Outstanding Growth 5YR AVG | N/A | 123.44% |